Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Bmy crawled date : 2021 - 04 - 16 save search
U.S. Food and Drug Administration Approves Opdivo® (nivolumab) in Combination with Chemotherapy for Patients with Advanced or Metastatic Gastric Cancer, Gastroesophageal Junction Cancer, and Esophageal Adenocarcinoma....
Published: 2021-04-16 (Crawled : 19:00) - biospace.com/
BMY | $48.51 0.48% 0.19% 9.8M
|
Health Technology
|
| O: 0.76%
H: 1.09%
C: 0.82%
food therapy cancer drug nivolumab
FDA approves nivolumab in combination with chemotherapy for metastatic gastric cancer and esophageal adenocarcinoma
Published: 2021-04-16 (Crawled : 18:04) - fda.gov
BMY | $48.51 0.48% 0.19% 9.8M
|
Health Technology
|
| O: 0.76%
H: 1.09%
C: 0.82%
cancer fda fda approval approval nivolumab
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published: 2021-04-16 (Crawled : 18:04) - fda.gov
PFE A | $25.91 0.19% -0.19% 28M
|
Health Technology
|
| O: 0.72%
H: 2.19%
C: 1.85%
LLY | $750.77 -0.12% -0.23% 1.8M
|
Health Technology
|
| O: 0.79%
H: 1.56%
C: 1.0%
BMY | $48.51 0.48% 0.19% 9.8M
|
Health Technology
|
| O: 0.76%
H: 1.09%
C: 0.82%
ABBV | $161.67 -0.38% -0.19% 3.4M
|
Health Technology
|
| O: 0.56%
H: 0.99%
C: 0.39%
YMAB | $14.91 3.76% 3.62% 300K
|
Health Technology
|
| O: 1.5%
H: 0.22%
C: -5.38%
VSTM | $11.07 -2.04% -2.08% 120K
|
Health Technology
|
| O: 1.12%
H: 0.0%
C: -1.47%
SNY | $46.24 0.68% 0.63% 1.6M
|
Health Technology
|
| O: 0.59%
H: 0.96%
C: 0.61%
RIGL | $1.15 -4.17% -3.45% 650K
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: -5.54%
REGN | $898.56 -0.68% -0.71% 360K
|
Health Technology
|
| O: 0.41%
H: 2.06%
C: 1.2%
KPTI | $1.155 -5.33% -5.63% 810K
|
Health Technology
|
| O: -0.26%
H: 2.95%
C: 0.47%
INCY | $53.43 -0.78% -0.8% 1.6M
|
Health Technology
|
| O: 0.5%
H: 0.3%
C: -1.12%
ILMN | $121.16 -4.65% -4.86% 1.2M
|
Health Technology
|
| O: -0.02%
H: 0.12%
C: -0.72%
EXEL 4 | $22.7 -0.48% -0.51% 1.8M
|
Health Technology
|
| O: -0.17%
H: 0.84%
C: -1.34%
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
|
| O: 0.97%
H: 0.24%
C: -2.59%
CLVS | $0.0812 -3.94%
|
Health Technology
|
| O: -0.66%
H: 1.16%
C: -1.32%
BPMC | $85.18 -2.37% -2.42% 510K
|
Health Technology
|
| O: 1.16%
H: 0.0%
C: -1.92%
BGNE S | $138.4 -2.05% -2.1% 210K
|
Health Technology
|
| O: -0.07%
H: 0.18%
C: -0.67%
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: -0.95%
H: 0.16%
C: -0.48%
AMGN | $265.51 -0.66% -0.67% 1.2M
|
Health Technology
|
| O: 0.51%
H: 0.93%
C: -0.28%
ALNY | $147.7 -0.54% -0.49% 330K
|
Health Technology
|
| O: 0.41%
H: 0.34%
C: -0.51%
AGIO | $29.26 -0.85% -0.75% 620K
|
Health Technology
|
| O: -0.45%
H: 2.17%
C: -0.18%
cancer approval
FDA Approves First Immunotherapy for Initial Treatment of Gastric Cancer
Published: 2021-04-16 (Crawled : 17:00) - fda.gov
BMY | $48.51 0.48% 0.19% 9.8M
|
Health Technology
|
| O: 0.76%
H: 1.09%
C: 0.82%
cancer treatment fda approval fda approval immunotherapy
Gainers vs Losers
| 45% | 55% |
Top 10 Gainers
KAVL | $6.3 135.96% 57.45% 44M
|
Wholesale Trade
PXMD | $0.74 79.7% 44.16% 4.5M
|
Health Technology
DYNT | $0.3704 -5.27% 43.09% 5.5M
|
Health Technology
LGVN P 3 d | $2.93 73.37% 42.52% 56M
|
HUBC | $1.95 50.0% 32.99% 73M
|
n/a
SPCB | $0.4004 45.07% 31.75% 130M
|
Electronic Technology
ONVO | $1.35 33.65% 24.62% 53M
|
Health Technology
OMQS | $0.7038 35.35% 24.3% 3.5M
|
Professional, Scientific, and T...
SNPO | $10.54 29.48% 22.88% 3.9M
|
EEIQ | $1.16 27.46% 20.86% 6.9K
|
Educational Services
Your saved searches
Save your searches and get alerts when important news are released.